Synerlab

Synerlab

A wide skillset from product development to contract-manufacturing and packaging.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
investor

€0.0

round
*

N/A

Buyout
Total Funding000k
More about Synerlab
Made with AI
Edit

Synerlab is a European Contract Development and Manufacturing Organization (CDMO) that specializes in pharmaceutical development, manufacturing, and packaging. The company serves a diverse range of clients, including both generic and non-generic pharmaceutical firms across Europe. Synerlab operates in the pharmaceutical industry, focusing on small to mid-size series production. The business model revolves around long-term partnerships with pharmaceutical companies, leveraging their expertise in industrial transfer, drug formulation, and clinical batch production from phase 1 to phase 3. Synerlab generates revenue through its comprehensive suite of services, which include research and development, galenics and analytics, and a wide range of manufacturing processes. The company continuously invests in enhancing its capacity and expanding its service offerings to meet the evolving needs of its clients.

Keywords: CDMO, pharmaceutical development, manufacturing, packaging, drug formulation, clinical batches, industrial transfer, Europe, long-term partnerships, flexibility.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Synerlab

Edit
Lyofal
ACQUISITION by Synerlab Nov 2012